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627Abstracts
jects were clinically typed into IBS category: constipation,
diarrhea or alternating. RESULTS: Correlations between
the EQ-5D visual analogue scale (EQ VAS) score and the
SF-36 subscales (available in the UK studies) were mod-
erate to high (r = 0.33 to 0.71, p < 0.01) with lower asso-
ciations seen with the mental health scores. Correlations
with the IBS-QOL (available in all studies) ranged from
0.33 to 0.54 (p < 0.01). Levels of responses to EQ-5D
items and the EQ VAS score were signiﬁcantly better for
control patients than for patients with IBS (all p < 0.01).
The EQ VAS was able to discriminate between levels of
pain severity (quartiles, p < 0.001; mild/moderate/severe,
p < 0.05) and general health severity (mild/moderate/
severe, p < 0.001). The EQ VAS was responsive in patients
with both a self-perceived and physician-rated improve-
ment in condition at 1 year (10.7-pt improvement, effect
and 8.7-pt improvement, ES = 0.47, respectively). CON-
CLUSIONS: The EQ-5D performs quite well in compar-
ison to the SF-36 (general) and IBS-QOL (disease-speciﬁc)
patient reported outcomes. It is a brief, valid and respon-
sive measure that can used to generate preference-based
valuations of health-related quality of life in patients with
IBS.
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OBJECTIVES: Estimate the prevalence and the quality 
of life of restless legs syndrome (RLS) in the French 
population 18 years of age or older. METHODS: A 
population-based survey was conducted among 10,000
adults through face to face interviews by using the quota
sampling method (on age, sex, geographical living 
area, economic working class and woman working
status). The screening was made with the 4 International
RLS Study Group (IRLSSG) criteria. Quality of life was
assessed with the SF-36 questionnaire among subjects 
suffering from RLS and a control group of 540 subjects
randomly selected among the global sample. RESULTS:
The population surveyed was representative of the 
French population. The lifetime prevalence of RLS (at
least one symptom episode in past life) was estimated:
9.2%, IC 95% = [8.3%; 10.2%]. The annual prevalence
of RLS (at least one symptom episode in the past year)
was estimated: 8.7%, IC 95% = [7.7%; 9.6%]. Among
RLS population, the sex ratio women to men was 2 to 
1 and the mean age at the time of the study was 48.5
years versus 46.5 years in the control group. After adjust-
ment on age and sex, all quality of life dimensions 
were worse in the RLS population than in the control
group: Physical Functioning: 82.7 vs. 87.2 (p < 0.001);
Role Functioning: 74.4 vs. 84.6 (p < 0.001); Bodily 
Pain: 63.7 vs. 75.1 (p < 0.001); General Health: 62.7 vs.
69.6 (p < 0.001); Vitality: 53.4 vs. 59.6 (p < 0.001); 
Social Functioning: 77.9 vs. 85.2 (p < 0.001); Reported
Health Transition: 75.0 vs. 84.0 (p < 0.001); Mental
Health: 62.3 vs. 68.3 (p < 0.001). CONCLUSIONS: RLS
is a frequent disease, it affects 9% of the French adult
population. This prevalence is consistent with the ﬁnd-
ings of studies from other countries. RLS has a signiﬁcant
impact on quality of life, as measured by the SF-36 
questionnaire.
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